DE69718506D1 - Neue verwendung von kreatin - Google Patents

Neue verwendung von kreatin

Info

Publication number
DE69718506D1
DE69718506D1 DE69718506T DE69718506T DE69718506D1 DE 69718506 D1 DE69718506 D1 DE 69718506D1 DE 69718506 T DE69718506 T DE 69718506T DE 69718506 T DE69718506 T DE 69718506T DE 69718506 D1 DE69718506 D1 DE 69718506D1
Authority
DE
Germany
Prior art keywords
creatine
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69718506T
Other languages
English (en)
Other versions
DE69718506T2 (de
Inventor
Marco Anelli
Ettore Strumia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11375243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69718506(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of DE69718506D1 publication Critical patent/DE69718506D1/de
Publication of DE69718506T2 publication Critical patent/DE69718506T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69718506T 1996-11-19 1997-11-10 Neue verwendung von kreatin Expired - Fee Related DE69718506T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria
PCT/EP1997/006225 WO1998022099A2 (en) 1996-11-19 1997-11-10 New use of creatine

Publications (2)

Publication Number Publication Date
DE69718506D1 true DE69718506D1 (de) 2003-02-20
DE69718506T2 DE69718506T2 (de) 2003-07-31

Family

ID=11375243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69718506T Expired - Fee Related DE69718506T2 (de) 1996-11-19 1997-11-10 Neue verwendung von kreatin

Country Status (13)

Country Link
US (1) US6242490B1 (de)
EP (1) EP0941081B1 (de)
CN (2) CN1623534A (de)
AR (1) AR009425A1 (de)
AT (1) ATE230983T1 (de)
BR (1) BR9713514A (de)
DE (1) DE69718506T2 (de)
DK (1) DK0941081T3 (de)
ES (1) ES2191206T3 (de)
IT (1) IT1298420B1 (de)
PT (1) PT941081E (de)
RU (1) RU2202345C2 (de)
WO (1) WO1998022099A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US9833427B2 (en) 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US20030212130A1 (en) * 2000-09-14 2003-11-13 Miller Donald W. Creatine ester anti-inflammatory compounds and formulations
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060025475A1 (en) * 2004-07-29 2006-02-02 Stanley Antosh Use of methyl pyruvate for the purpose of increasing muscle energy production.
US20060052448A1 (en) * 2004-09-04 2006-03-09 Mr. Stanley Antosh Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (de) 1973-06-27 1977-07-01 Biotherax Lab
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
WO1998000148A1 (de) 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink

Also Published As

Publication number Publication date
EP0941081B1 (de) 2003-01-15
ES2191206T3 (es) 2003-09-01
WO1998022099A3 (en) 1998-07-09
ATE230983T1 (de) 2003-02-15
ITMI962408A0 (it) 1996-11-19
DE69718506T2 (de) 2003-07-31
EP0941081A2 (de) 1999-09-15
IT1298420B1 (it) 2000-01-05
BR9713514A (pt) 2000-02-29
ITMI962408A1 (it) 1998-05-19
CN1237904A (zh) 1999-12-08
PT941081E (pt) 2003-04-30
RU2202345C2 (ru) 2003-04-20
US6242490B1 (en) 2001-06-05
AR009425A1 (es) 2000-04-12
DK0941081T3 (da) 2003-04-22
CN1623534A (zh) 2005-06-08
WO1998022099A2 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
DE69725205D1 (de) Befestigung von Biomolekülen
DE69718393D1 (de) Befestigung von Biomolekülen
DE69715827D1 (de) Verwendung von aloe extrakt enthaltenden zahnprothesehaftmitteln
DE69533361D1 (de) Umsetzung von kohlenwasserstoffen
DE69527527D1 (de) Verwendung von omega-hydrofluoralkylether
DE59905858D1 (de) Verwendung von pit-emulsionen
DE69732684D1 (de) Automatische Modifizierung von Dokumentgestaltungen
DE69720111T2 (de) Vorläufer von Duftstoffen
DE69518454D1 (de) Abschätzung von Anregungsparametern
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
ATE288207T1 (de) Verwendung von 1-nonen-3-one als aromastoff
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE69718506D1 (de) Neue verwendung von kreatin
DE69717677T2 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE69500881T3 (de) Oxidation von uranhexafluorid
DE69519381T2 (de) Modifizierung von ölen
DE69513864D1 (de) Verwendung von Polyketon /HDPE Mischungen
DE59705708D1 (de) Lagebestimmung von peripherieeinheiten
DE69711223T2 (de) Verwendung von cordia dichotoma extrakten
DE69522582T2 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
DE69602155T2 (de) Verbesserung von Branntweinen
DE19781649T1 (de) Herstellung von länglichen Elementen
DE59700206D1 (de) Verwendung von Schichtsilikaten
DE59807752D1 (de) Verwendung von wasserverdünnbaren beschichtungszusammensetzungen
DE59501871D1 (de) Monocarbonsäureamide von Polyaminen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee